1. State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants.
- Author
-
Harrison, Jordan M., Kerber, Rose, Andraka-Christou, Barbara, Sorbero, Mark, and Stein, Bradley D.
- Subjects
- *
PHYSICIANS' assistants , *NURSE prescribing , *NURSE practitioners , *OPIOID abuse , *BUPRENORPHINE - Abstract
Nurse practitioner (NP) and physician assistant (PA) prescribing can increase access to buprenorphine treatment for opioid use disorder. In this cross-sectional study, we used deidentified claims from approximately 90% of U.S. retail pharmacies (2017โ2018) to examine the association of state policies with the odds of receiving buprenorphine treatment from an NP/PA versus a physician, overall and stratified by urban/rural status. From 2017 to 2018, the percentage of buprenorphine treatment episodes prescribed by NPs/PAs varied widely across states, from 0.4% in Alabama to 57.2% in Montana. Policies associated with greater odds of buprenorphine treatment from an NP/PA included full scope of practice (SOP) for NPs, full SOP for PAs, Medicaid pay parity for NPs (reimbursement at 100% of the fee-for-service physician rate), and Medicaid expansion. Although most findings with respect to policies were similar in urban and rural settings, the association of Medicaid expansion with NP/PA buprenorphine treatment was driven by rural counties. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF